MATERAZZI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 16.025
EU - Europa 8.114
AS - Asia 3.700
AF - Africa 356
SA - Sud America 127
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.334
Nazione #
US - Stati Uniti d'America 15.657
IT - Italia 3.689
CN - Cina 1.999
SE - Svezia 1.283
DE - Germania 1.053
SG - Singapore 814
BG - Bulgaria 655
TR - Turchia 373
GB - Regno Unito 366
CA - Canada 361
VN - Vietnam 262
FI - Finlandia 218
CI - Costa d'Avorio 209
AT - Austria 191
UA - Ucraina 182
RU - Federazione Russa 146
BR - Brasile 99
IN - India 99
SN - Senegal 96
HK - Hong Kong 86
CH - Svizzera 82
FR - Francia 71
NL - Olanda 50
BE - Belgio 37
NG - Nigeria 34
CZ - Repubblica Ceca 16
ES - Italia 13
IR - Iran 13
PL - Polonia 9
CL - Cile 8
KR - Corea 8
RO - Romania 8
AU - Australia 7
IE - Irlanda 7
CO - Colombia 6
GR - Grecia 6
HU - Ungheria 6
ID - Indonesia 6
JP - Giappone 6
AR - Argentina 5
BJ - Benin 5
IQ - Iraq 5
TW - Taiwan 5
BD - Bangladesh 4
LT - Lituania 4
MX - Messico 4
DK - Danimarca 3
EC - Ecuador 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
MA - Marocco 3
PK - Pakistan 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
AL - Albania 2
BY - Bielorussia 2
EE - Estonia 2
JO - Giordania 2
KZ - Kazakistan 2
PE - Perù 2
SV - El Salvador 2
TN - Tunisia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 28.334
Città #
Woodbridge 1.786
Fairfield 1.753
Chandler 1.282
Houston 1.267
Ann Arbor 1.221
Santa Clara 1.056
Ashburn 978
Seattle 707
Milan 677
Shanghai 649
Sofia 646
Wilmington 606
Cambridge 604
New York 433
Singapore 422
Beijing 412
Serra 401
Ottawa 335
Boardman 325
Princeton 306
Lawrence 267
Izmir 252
Jacksonville 249
Medford 228
Abidjan 209
Florence 207
Nanjing 200
Vienna 180
Pisa 159
Rome 156
Des Moines 152
Dong Ket 132
Dearborn 111
Istanbul 106
San Diego 102
Dakar 96
Hong Kong 81
London 81
Frankfurt am Main 79
Bern 72
Bremen 66
Nanchang 62
Ogden 61
Redwood City 56
Kunming 53
Lancaster 52
Jüchen 47
Hebei 44
Los Angeles 44
Naples 44
Boulder 42
Changsha 38
Falls Church 35
Bologna 33
Brussels 33
Fuzhou 33
Lagos 33
Shenyang 33
Washington 32
Norwalk 30
Hefei 29
Lucca 29
Jiaxing 28
Tianjin 27
Dallas 25
Quanzhou 25
Guangzhou 24
Marseille 23
Pune 22
Hangzhou 20
Nürnberg 20
Helsinki 19
San Francisco 19
Phoenix 18
Rho 18
Toronto 18
Munich 17
Palermo 17
Piscataway 17
Turin 17
Verona 17
Jinan 16
Vicopisano 16
Wuhan 16
Chicago 15
Livorno 15
Massa 15
Zhengzhou 15
Cagliari 14
Düsseldorf 14
Kent 14
Napoli 14
Pontedera 14
Redmond 14
Hyderabad 13
Catania 12
Grafing 12
Indiana 12
Lanzhou 12
Auburn Hills 11
Totale 20.569
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 897
Fistole del seno piriforme in un adolescente 800
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 275
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 270
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 174
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 173
Acquired Carotid-Jugular Fistula: Its Changing History and Management 172
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 172
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 169
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 169
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 167
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 165
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 164
null 160
null 157
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 154
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 153
Video-assisted thyroidectomy: indications and results 152
Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed. 152
Modified lateral neck lymphadenectomy: prospective randomized study comparing harmonic scalpel with clamp-and-tie technique 151
Minimally invasive video-assisted thyroidectomy (MIVAT) from A to Z 151
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 149
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 148
Evaluation of a new ultrasonic device in thyroid surgery: comparative randomized study 148
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 147
Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy. 145
Aggressive thyroid cancer: targeted therapy with sorafenib 145
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 145
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 144
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 144
Minimally invasive thyroidectomy in the treatment of well differentiated thyroid cancers: indications and limits 143
Sorafenib and Thyroid Cancer 141
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 140
Silent Pheocromocytoma presenting as tako-Tsubo syndrom during anesthesiological stress. 139
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 138
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 138
Conservative management of a tracheal leakage occurring 40 days after robotic thyroidectomy 138
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 136
Minimally Invasive Videoassisted thyroidectomy 136
Endoscopic Parathyroidectomy 135
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 134
The extent of surgery in thyroglossal cyst carcinoma 134
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 133
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 133
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 132
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 131
Sorafenib in the treatment of thyroid cancer 131
Cabozantinib in Thyroid Cancer 130
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 128
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 126
Track Recurrence after Robotic Transaxillary Thyroidectomy: A Case Report Highlighting the Importance of Controlled Surgical Indications and Addressing Unprecedented Complications 126
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 125
Cosmetic result and overall satisfaction after minimally invasive video-assisted thyroidectomy (MIVAT) versus robot-assisted transaxillary thyroidectomy (RATT): A prospective randomized study 124
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 124
The necessity for a thoracic approach in thyroid surgery 123
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 123
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 123
Postoperative Pain Evaluation After Robotic Transaxillary Thyroidectomy Versus Conventional Thyroidectomy: A Prospective Study 123
null 122
ANTIGENIC EXPRESSION OF M2 PYRUVATE-KINASE IN COLON RECTAL CANCER.PRELIMINARY RESULTS OF AN IMMUNOISTCHEMICAL STUDY 121
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 121
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 121
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 121
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis 120
Minimally Invasive Video-Assisted Parathyroidectomy: Lesson Learned from 137 cases 119
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 119
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas 119
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 119
Minimally invasive approach to the cervical spine: a proposal 118
Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules: An Efficient and Safe Alternative to Surgery 118
Minimally invasive, video-assisted thyroidectomy (MIVAT) 117
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 117
Minimally invasive video-assisted thyroidectomy in pediatric patients 116
Letter 1: Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day-case procedure (Br J Surg 2004; 91: 78-82) 115
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 115
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 115
EVIDENCE OF A LOW PREVALENCE OF RAS MUTATIONS IN A LARGE MEDULLARY THYROID CANCER SERIES 115
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 115
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation 114
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer 114
Impact of harmonic scalpel on operative time during video-assisted thyroidectomy 114
Peduncolated adenomas with invasive carcinoma removed endoscopically . Is it necessary surgical treatment? 113
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 113
Minimally invasive video-assisted thyroidectomy 113
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 113
Differences in miRNA expression profiles between wild-type and mutated NIFTPs 113
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 113
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 112
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 112
Combination of mini-invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders 111
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. 111
Selective use of vandetanib in the treatment of thyroid cancer 111
Results of video-assisted parathyroidectomy: single institution's six-year experience 111
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness 110
Adrenal surgery before and after the introduction of laparoscopic adrenalectomy 110
Novel treatment options for anaplastic thyroid cancer 110
Dedifferentiated thyroid cancer: a therapeutic challenge 109
Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience 108
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 107
Mini-invasive video-assisted surgery of the thyroid and parathyroid glands: A 2011 update 107
Totale 14.811
Categoria #
all - tutte 86.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.341 0 0 0 0 0 0 532 383 564 350 393 119
2020/20212.145 226 129 130 81 175 137 189 199 203 185 148 343
2021/20223.042 75 144 101 184 557 440 73 137 169 98 180 884
2022/20234.202 487 549 288 349 447 501 62 337 741 48 317 76
2023/20243.453 357 318 388 297 478 565 192 135 107 87 198 331
2024/20253.570 136 386 156 600 897 1.060 335 0 0 0 0 0
Totale 28.950